🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎉Day 3 at #HRS2024! Visit us at Booth 447 to explore how the investigational #WiSECRT System overcomes CRT challenges with #leadless precision. #epeeps #LVEP

Experience how #WiSECRT System is being developed for CRT patients at Booth 447 with our interactive simulator. #HRS2024. #LVEP

As #HRS2024 ends, we thank everyone who explored the investigational #WiSECRT System. Let's continue redefining cardiac care together! Thank you #epeeps! #leadless #LVEP

Congratulations to Dr Elisabetta Montemerlo from Fondazione IRCCS San Gerardo dei Tintori for winning Best Abstract for her presentation on SOLVE-CRT Randomized Results at the PLACE Conference held in Rome.

🎉 EBR is honored to be JAMA Cardiology Editor Choice for our publication of SOLVE-CRT results! The study met its safety and efficacy endpoints, showing a 16.4% improvement in LVESV at 6-months for the investigational WiSE CRT System. Read more: ow.ly/rZCA50SOC8g

EBR Systems President and CEO John McCutheon joins Fraser Palamara on Stockhead TV to talk about the company’s recent FDA submission. ow.ly/qCII50TgWk6

Excited to announce Mike Minacci as Director, US Sales at EBR Systems! With 20+ years in medical device sales leadership at St. Jude Medical, Boston Scientific, and AtriCure is set to drive our growth. Welcome, Mike!

Thank you to 🩺 Dr. Niraj Varma of Cleveland Clinic who spoke at the 2025 Stanford Biodesign symposium, highlighting the newly FDA-approved WiSE System. He addressed CRT challenges and how leadless LV endocardial pacing (LVEP) offers a new path forward for heart failure care.

Welcome to San Diego #HRS2025! The FDA-approved WiSE System is here—setting a new standard in CRT as the only leadless LV endocardial pacing device. Booth opens tomorrow, see you 🔜 #LVEP

🏁 Booth 2526 is OPEN! Explore the FDA-approved WiSE System—now the only leadless LVEP device available for CRT. Come test out our implant simulator and see it in action. #HRS2025 #epeeps

instagram.com/reel/DI51VUexe…

💡 FDA-approved and leadless: The WiSE System delivers LV endocardial pacing without a CS lead. Experience the system and try the simulator at Booth 2526. #HRS2025 #LVEP

As #HRS2025 ends, we proudly celebrate FDA approval of the WiSE System—a major step for cardiac care. Thank you to everyone who supported us and visited this week to experience the future of CRT. Let’s keep driving patient innovation forward. #LVEP #epeeps 💙

Please share this opportunity with colleagues and friends! The Fogarty Prize recognizes an individual or team who has developed and commercialized a singular medical technology that has meaningfully advanced patient care. #medtech #innovation #impact

Break it Down: EBR Systems, Inc. completes first US commercial implants of WiSE CRT system. Watch the video here: buff.ly/ydsFJwe #ASX #Medtech $EBR

First U.S. commercial implants of the FDA-approved WiSE System are complete—thanks to 🫀 Dr. Robert Canby + team at StDavid'sHealthCare 🫀 Dr. Niraj Varma Cleveland Clinic Leadless LVEP is here for heart failure patients who had no other options. Press Release: loom.ly/3112mZs

Vital Signs Podcast: EBR Systems, Inc. major milestones in WiSE CRT commercialisation buff.ly/gJUqb5H #ASX #Medtech $EBR

Vital Signs Podcast: EBR’s major milestones in WiSE CRT commercialisation stockhead.com.au/health/vital-s…

Congratulations to Fogarty company-in-residence, Materna Medical on the completion of a recent close within an ongoing $20 million Series B2 round & the new commercial name for its second product, Ellora™ (formerly Materna Prep)! More: businesswire.com/news/home/2025…